Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Chesterford Research Park, Little Chesterford, England, CB10 1XL, GB
Collaboration aims to bring innovative treatment options to patients with advanced small cell lung cancer.
By: Charlie Sternberg
Through the agreement, Gilead will gain access to Tubulis’ Tubutecan and Alco5 platforms.
By: Kristin Brooks
To co-develop BL-B01D1, a potentially first-in-class bispecific EGFRxHER3 ADC with potential to treat lung and breast cancer.
Myricx to develop an antibody discovered based on WuXi Bio’s tech platforms for difficult-to-treat solid tumors.
BMS to obtain access to Tubulis’ P5 conjugation and Tubutecan platforms to develop customizable antibody-drug conjugates for cancer.
By: Anthony Vecchione
Collaboration will add a new class of precision medicine therapeutics to BioNTech’s clinical-stage oncology portfolio.
Aims to launch one new product or indication every 1.5 years on average, in oncology, neurology and immunology.
Adds custom radiolabelling and preclinical, integrated drug discovery services
Cypralis will have exclusive development and commercialization rights to certain macrocyclic inhibitors
Anticancer compound shows potential in pancreatic cancer, breast cancer, small-cell lung cancer and uterine sarcoma
Aims to develop new cyclophilin inhibitors for neurodegenerative diseases
Will further develop and market anti-cancer drug CZ-48
By: Tim Wright
No option but to outsource?
By: Enrico Polastro
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
